Detalles de la búsqueda
1.
Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials.
Haematologica
; 107(9): 2051-2063, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34788984
2.
Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysis.
Br J Haematol
; 184(6): 957-968, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30548597
3.
Delineating outcomes of patients with diffuse large b cell lymphoma using the national comprehensive cancer network-international prognostic index and positron emission tomography-defined remission status; a population-based analysis.
Br J Haematol
; 172(2): 246-54, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26577576
4.
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.
Blood
; 123(6): 843-50, 2014 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24277073
5.
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial.
Haematologica
; 98(6): 945-52, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23349309
6.
Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score? Reply to Adams and Kwee.
Br J Haematol
; 177(2): 320-321, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27018322
7.
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
Leukemia
; 36(3): 625-636, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34657128
8.
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial.
Lancet Haematol
; 9(4): e262-e275, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35358441
9.
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
Blood
; 113(19): 4489-96, 2009 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-19244158
10.
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).
Blood
; 114(25): 5136-45, 2009 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19828704
11.
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial.
Blood Adv
; 5(17): 3322-3332, 2021 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34477813
12.
Favourable outcomes for high-risk Burkitt lymphoma patients (IPI 3-5) treated with rituximab plus CODOX-M/IVAC: Results of a phase 2 UK NCRI trial.
EJHaem
; 1(1): 133-141, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35847742
13.
Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings.
J Clin Pathol
; 67(5): 389-95, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24327662
14.
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
Blood
; 109(3): 944-50, 2007 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17032921
Resultados
1 -
14
de 14
1
Próxima >
>>